Elite Pharma Stock Performance
| ELTP Stock | USD 0.39 0.02 4.88% |
The firm shows a Beta (market volatility) of 0.83, which means possible diversification benefits within a given portfolio. As returns on the market increase, Elite Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Elite Pharma is expected to be smaller as well. At this point, Elite Pharma has a negative expected return of -0.65%. Please make sure to confirm Elite Pharma's maximum drawdown, as well as the relationship between the accumulation distribution and price action indicator , to decide if Elite Pharma performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Elite Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with fragile performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2026. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
| Begin Period Cash Flow | 3.6 M | |
| Total Cashflows From Investing Activities | -498.6 K |
Elite |
Elite Pharma Relative Risk vs. Return Landscape
If you would invest 60.00 in Elite Pharma on November 6, 2025 and sell it today you would lose (21.00) from holding Elite Pharma or give up 35.0% of portfolio value over 90 days. Elite Pharma is currently does not generate positive expected returns and assumes 3.2616% risk (volatility on return distribution) over the 90 days horizon. In different words, 29% of otc stocks are less volatile than Elite, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Elite Pharma Target Price Odds to finish over Current Price
The tendency of Elite OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.39 | 90 days | 0.39 | about 97.0 |
Based on a normal probability distribution, the odds of Elite Pharma to move above the current price in 90 days from now is about 97.0 (This Elite Pharma probability density function shows the probability of Elite OTC Stock to fall within a particular range of prices over 90 days) .
Elite Pharma Price Density |
| Price |
Predictive Modules for Elite Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Elite Pharma. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Elite Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Elite Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Elite Pharma is not an exception. The market had few large corrections towards the Elite Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Elite Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Elite Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.7 | |
β | Beta against Dow Jones | 0.83 | |
σ | Overall volatility | 0.06 | |
Ir | Information ratio | -0.22 |
Elite Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Elite Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Elite Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Elite Pharma generated a negative expected return over the last 90 days | |
| Elite Pharma has some characteristics of a very speculative penny stock | |
| Elite Pharma has high historical volatility and very poor performance | |
| About 18.0% of the company shares are held by company insiders |
Elite Pharma Fundamentals Growth
Elite OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Elite Pharma, and Elite Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Elite OTC Stock performance.
| Return On Equity | 0.27 | |||
| Return On Asset | 0.0739 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 27.92 M | |||
| Shares Outstanding | 1.01 B | |||
| Price To Earning | 5.21 X | |||
| Price To Book | 1.12 X | |||
| Price To Sales | 0.92 X | |||
| Revenue | 32.26 M | |||
| EBITDA | 7.93 M | |||
| Cash And Equivalents | 19.78 M | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 1.39 M | |||
| Debt To Equity | 0.57 % | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | 6.51 M | |||
| Earnings Per Share | 0.01 X | |||
| Total Asset | 35.15 M | |||
| Retained Earnings | (147.41 M) | |||
| Current Asset | 19.66 M | |||
| Current Liabilities | 5.13 M | |||
About Elite Pharma Performance
Assessing Elite Pharma's fundamental ratios provides investors with valuable insights into Elite Pharma's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Elite Pharma is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey. Elite Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 43 people.Things to note about Elite Pharma performance evaluation
Checking the ongoing alerts about Elite Pharma for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Elite Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Elite Pharma generated a negative expected return over the last 90 days | |
| Elite Pharma has some characteristics of a very speculative penny stock | |
| Elite Pharma has high historical volatility and very poor performance | |
| About 18.0% of the company shares are held by company insiders |
- Analyzing Elite Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Elite Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Elite Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Elite Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Elite Pharma's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Elite Pharma's otc stock. These opinions can provide insight into Elite Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Elite OTC Stock Analysis
When running Elite Pharma's price analysis, check to measure Elite Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elite Pharma is operating at the current time. Most of Elite Pharma's value examination focuses on studying past and present price action to predict the probability of Elite Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elite Pharma's price. Additionally, you may evaluate how the addition of Elite Pharma to your portfolios can decrease your overall portfolio volatility.